Cleared Special

OMNI-VUE 2 SYSTEM (K130374) - FDA 510(k) Clearance

Class II Radiology device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K130374 · Genesis Digital Imaging, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2013
Decision
196d
Days
Class 2
Risk

K130374 is an FDA 510(k) clearance for the OMNI-VUE 2 SYSTEM. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Genesis Digital Imaging, Inc. (Denton, US). The FDA issued a Cleared decision on August 29, 2013 after a review of 196 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Genesis Digital Imaging, Inc. devices

Submission Details

510(k) Number K130374 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 14, 2013
Decision Date August 29, 2013
Days to Decision 196 days
Submission Type Special
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
89d slower than avg
Panel avg: 107d · This submission: 196d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 730
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K130374.
SCENIUM
K133654 · Siemens Medical Solutions USA, Inc. · Feb 2014
SYNGO.VIA MI WORKFLOWS
K133644 · Siemens Medical Solutions USA, Inc. · Feb 2014
DYONICS PLAN HIP IMPINGEMENT PLANNING SYSTEM
K132636 · Smith & Nephew, Inc. · Oct 2013
SYNGO.MR GENERAL
K130749 · Siemens Medical Solutions USA, Inc. · Aug 2013
ESIE APPS SUITE
K132062 · Siemens Medical Solutions USA, Inc. · Jul 2013
SYNGO, BREAST CARE
K123420 · Siemens Medical Solutions USA, Inc. · Feb 2013